Castle Biosciences (CSTL) Inventory (2018 - 2026)

Castle Biosciences (CSTL) has 9 years of Inventory data on file, last reported at $10.5 million in Q1 2026.

• Quarterly Inventory rose 52.74% year-over-year to $10.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $10.5 million (up 52.74% YoY) and the FY2025 annual result came in at $10.3 million, up 26.05% from the prior year.
• Inventory grew to $10.5 million in Q1 2026 per CSTL's latest filing, from $10.3 million in the prior quarter.
• The five-year high for Inventory was $10.5 million in Q1 2026, with the low at $2.4 million in Q1 2022.
• Average Inventory over 5 years is $6.6 million, with a median of $6.8 million recorded in 2025.
• Year-over-year, Inventory soared 99.55% in 2023 and retreated 10.41% in 2025.
• Castle Biosciences' Inventory stood at $4.0 million in 2022, then soared by 99.55% to $7.9 million in 2023, then advanced by 2.43% to $8.1 million in 2024, then grew by 26.05% to $10.3 million in 2025, then climbed by 2.02% to $10.5 million in 2026.
• Business Quant data shows CSTL's Inventory at $10.5 million in Q1 2026, $10.3 million in Q4 2025, and $8.6 million in Q3 2025.